Clinical trial
TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
NCT03630536 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 12, 2018
- Completion date
- April 1, 2026
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal cell carcinoma